Dr Dheeraj Kumar Bobba, MD | |
7525 E Broadway Rd Ste 9, Mesa, AZ 85208-1156 | |
(480) 981-2700 | |
(480) 981-8399 |
Full Name | Dr Dheeraj Kumar Bobba |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 22 Years |
Location | 7525 E Broadway Rd Ste 9, Mesa, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588878508 | NPI | - | NPPES |
256541-01 | Medicaid | AZ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | MT 183329 (Pennsylvania) | Secondary |
207R00000X | Internal Medicine | 37192 (Arizona) | Secondary |
208M00000X | Hospitalist | 37192 (Arizona) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Banner Baywood Medical Center | Mesa, AZ | Hospital |
Banner Heart Hospital | Mesa, AZ | Hospital |
Banner Desert Medical Center | Mesa, AZ | Hospital |
Advanced Healthcare Of Mesa | Mesa, AZ | Nursing home |
Montecito Post Acute Care And Rehabilitation | Mesa, AZ | Nursing home |
Estrella Center | Avondale, AZ | Nursing home |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Allied Medical Associates Plc | 0840614566 | 6 |
Allied Internal Medicine Pllc | 7315251964 | 22 |
News Archive
For researchers investigating Alzheimer's Disease (AD), a devastating neurodegenerative illness afflicting close to 6 million Americans, it is the best and worst of times.
Several lines of research have opened exciting new frontiers in scientific understanding and clinical management of bipolar disorder. Recent advances in bipolar disease research are described in this month's special issue of Harvard Review of Psychiatry.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that new preclinical data investigating the role of microRNA-21 (miR-21) in the treatment of kidney fibrosis has been published in the journal Science Translational Medicine.
Calculating blood pressure load does not increase physicians' ability to predict a patient's risk of cardiovascular events, research shows.
New research from Cedars-Sinai has identified neurons that play a role in how people recognize errors they make, a discovery that may have implications for the treatment of conditions including obsessive-compulsive disorder and schizophrenia.
› Verified 3 days ago
Entity Name | Hospitalists Of Arizona, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578564860 PECOS PAC ID: 2163335290 Enrollment ID: O20031112000571 |
News Archive
For researchers investigating Alzheimer's Disease (AD), a devastating neurodegenerative illness afflicting close to 6 million Americans, it is the best and worst of times.
Several lines of research have opened exciting new frontiers in scientific understanding and clinical management of bipolar disorder. Recent advances in bipolar disease research are described in this month's special issue of Harvard Review of Psychiatry.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that new preclinical data investigating the role of microRNA-21 (miR-21) in the treatment of kidney fibrosis has been published in the journal Science Translational Medicine.
Calculating blood pressure load does not increase physicians' ability to predict a patient's risk of cardiovascular events, research shows.
New research from Cedars-Sinai has identified neurons that play a role in how people recognize errors they make, a discovery that may have implications for the treatment of conditions including obsessive-compulsive disorder and schizophrenia.
› Verified 3 days ago
Entity Name | Banner Hospital Based Physicians Arizona Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275889891 PECOS PAC ID: 3274782487 Enrollment ID: O20121003000752 |
News Archive
For researchers investigating Alzheimer's Disease (AD), a devastating neurodegenerative illness afflicting close to 6 million Americans, it is the best and worst of times.
Several lines of research have opened exciting new frontiers in scientific understanding and clinical management of bipolar disorder. Recent advances in bipolar disease research are described in this month's special issue of Harvard Review of Psychiatry.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that new preclinical data investigating the role of microRNA-21 (miR-21) in the treatment of kidney fibrosis has been published in the journal Science Translational Medicine.
Calculating blood pressure load does not increase physicians' ability to predict a patient's risk of cardiovascular events, research shows.
New research from Cedars-Sinai has identified neurons that play a role in how people recognize errors they make, a discovery that may have implications for the treatment of conditions including obsessive-compulsive disorder and schizophrenia.
› Verified 3 days ago
Entity Name | Allied Internal Medicine Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124408232 PECOS PAC ID: 7315251964 Enrollment ID: O20150917003141 |
News Archive
For researchers investigating Alzheimer's Disease (AD), a devastating neurodegenerative illness afflicting close to 6 million Americans, it is the best and worst of times.
Several lines of research have opened exciting new frontiers in scientific understanding and clinical management of bipolar disorder. Recent advances in bipolar disease research are described in this month's special issue of Harvard Review of Psychiatry.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that new preclinical data investigating the role of microRNA-21 (miR-21) in the treatment of kidney fibrosis has been published in the journal Science Translational Medicine.
Calculating blood pressure load does not increase physicians' ability to predict a patient's risk of cardiovascular events, research shows.
New research from Cedars-Sinai has identified neurons that play a role in how people recognize errors they make, a discovery that may have implications for the treatment of conditions including obsessive-compulsive disorder and schizophrenia.
› Verified 3 days ago
Entity Name | Allied Medical Associates Plc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114541752 PECOS PAC ID: 0840614566 Enrollment ID: O20200728000530 |
News Archive
For researchers investigating Alzheimer's Disease (AD), a devastating neurodegenerative illness afflicting close to 6 million Americans, it is the best and worst of times.
Several lines of research have opened exciting new frontiers in scientific understanding and clinical management of bipolar disorder. Recent advances in bipolar disease research are described in this month's special issue of Harvard Review of Psychiatry.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that new preclinical data investigating the role of microRNA-21 (miR-21) in the treatment of kidney fibrosis has been published in the journal Science Translational Medicine.
Calculating blood pressure load does not increase physicians' ability to predict a patient's risk of cardiovascular events, research shows.
New research from Cedars-Sinai has identified neurons that play a role in how people recognize errors they make, a discovery that may have implications for the treatment of conditions including obsessive-compulsive disorder and schizophrenia.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Dheeraj Kumar Bobba, MD Po Box 20610, Mesa, AZ 85277-0610 Ph: (480) 985-1093 | Dr Dheeraj Kumar Bobba, MD 7525 E Broadway Rd Ste 9, Mesa, AZ 85208-1156 Ph: (480) 981-2700 |
News Archive
For researchers investigating Alzheimer's Disease (AD), a devastating neurodegenerative illness afflicting close to 6 million Americans, it is the best and worst of times.
Several lines of research have opened exciting new frontiers in scientific understanding and clinical management of bipolar disorder. Recent advances in bipolar disease research are described in this month's special issue of Harvard Review of Psychiatry.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that new preclinical data investigating the role of microRNA-21 (miR-21) in the treatment of kidney fibrosis has been published in the journal Science Translational Medicine.
Calculating blood pressure load does not increase physicians' ability to predict a patient's risk of cardiovascular events, research shows.
New research from Cedars-Sinai has identified neurons that play a role in how people recognize errors they make, a discovery that may have implications for the treatment of conditions including obsessive-compulsive disorder and schizophrenia.
› Verified 3 days ago
Gregg Alan Smith, D.O. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 1042 N Higley Rd, Suite 102-602, Mesa, AZ 85205 Phone: 480-242-6297 Fax: 480-699-3129 | |
Dr. Fayz Yar Khan, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10238 E Hampton Ave, Mesa, AZ 85209 Phone: 480-354-6463 | |
Dr. Marwan Mohammed Oleiwi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6644 E Baywood Ave, Banner Baywood Medical Center, Mesa, AZ 85206 Phone: 480-321-3900 Fax: 480-321-3840 | |
Dr. Pawan A Dhawan, MBBS Hospitalist Medicare: Medicare Enrolled Practice Location: Bdmc/attn: Bmg Hospitalists, 1400 S Dobson Road, Mesa, AZ 85202 Phone: 480-412-6788 Fax: 480-412-6848 | |
Dr. Katelyn Rheault, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6644 E Baywood Ave, Mesa, AZ 85206 Phone: 602-839-3644 | |
Dr. Lloyd Centino, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: Banner Desert Medical Center Attn Hospitalist, 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 480-412-6788 Fax: 480-412-6848 | |
Dr. Ritesh Kanotra, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6644 E Baywood Ave, Banner Baywood Medical Center, Mesa, AZ 85206 Phone: 480-321-3900 Fax: 480-321-3840 |